Loading...
Bienvenue dans la collection HAL I2MC
L’Institut des Maladies Métaboliques et Cardiovasculaires (I2MC) développe des recherches pour comprendre les mécanismes physiopathologiques impliquées dans des maladies chroniques non transmissibles extrêmement fréquentes : obésité, diabète, thrombose, athérosclérose, maladies des vaisseaux, du cœur et du rein.

Taux d'open access
72 %
Sujets
Autophagie
Lipids
Diabetes
Métabolisme
Signaling
Oxylipins
Opuntia
Lipolysis
Chronic kidney disease
Microgravity
Inflammation
Cardiogenic shock
Fatty acids
Lipidomics
Sepsis
Obésité
Metabolic syndrome
Phosphoinositides
COVID-19
Proteomics
Adipose tissue
Mitochondria
Fibrosis
Ageing
Lymphedema
Heart
Cerebral autoregulation
Kidney
Microbiota
Healthy aging
GPCR
Epidemiology
Atherosclerosis
Biomarker
Senescence
Risk factors
Mice
Lipogenesis
Amine oxidases
Endothelium
Heart failure
Hypertrophy
Intensive care unit
Periodontitis
Insulin resistance
Diet
Endothelial cells
Gene expression
Mass spectrometry
Aging
Autophagy
Lipid metabolism
Angiogenesis
Gut microbiota
Estrogen receptor
Myocardial infarction
Oxidative stress
Apoptosis
Mechanical ventilation
Preeclampsia
Older adults
Macrophages
Skeletal muscle
Atrial fibrillation
Mouse
Reactive oxygen species
Metabolism
Stroke
HDL
Mortality
Cholesterol
Breast cancer
Steatosis
Lipidomic
Menopause
Diabète de type 2
Autonomic nervous system
Type 2 diabetes
Cardiomyocyte
Prognosis
Megakaryocytes
Cancer
Adipocyte
Insuffisance cardiaque
Biomarkers
Immune response
Oral microbiota
Liver
Adipocytes
Athérosclérose
Cardiovascular disease
Multiple system atrophy
Insulin
Glucose transport
Thrombosis
Urine
Platelets
Metabolic diseases
Obesity
Metabolomics
Dernières publications
-
Salwa Soussi, Angela Serena Maione, Lise Lefèvre, Nathalie Pizzinat, Jason Iacovoni, et al.. Analysis of effector/memory regulatory T cells from arrhythmogenic cardiomyopathy patients identified IL-32 as a novel player in ACM pathogenesis. Cell Death and Disease, 2025, 16 (1), pp.87. ⟨10.1038/s41419-025-07364-y⟩. ⟨hal-04942140⟩
-
-
-
-
-
-
Loïc Ysebaert, Caroline Protin, Lucie Obéric, Guillaume Beziat, Sandra de Barros, et al.. Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertension. Journal of Hypertension, 2024, Online ahead of print. ⟨10.1097/hjh.0000000000003937⟩. ⟨inserm-04906955⟩